Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.
Official title: A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
1
Start Date
2025-06-19
Completion Date
2025-07-29
Last Updated
2026-08-31
Healthy Volunteers
No
Conditions
Interventions
LY3549492
Administered orally
Placebo
Administered orally
Locations (42)
HOPE Research Institute
Phoenix, Arizona, United States
Headlands Research - Scottsdale
Scottsdale, Arizona, United States
NorCal Medical Research, Inc
Greenbrae, California, United States
Velocity Clinical Research, Huntington Park
Huntington Park, California, United States
Peninsula Research Associates
Rolling Hills Estates, California, United States
Diablo Clinical Research, Inc.
Walnut Creek, California, United States
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
Northeast Research Institute (NERI)
Fleming Island, Florida, United States
Indago Research & Health Center, Inc
Hialeah, Florida, United States
New Horizon Research Center
Miami, Florida, United States
Suncoast Clinical Research, Inc.
New Port Richey, Florida, United States
Charter Research - Winter Park
Orlando, Florida, United States
Charter Research - Lady Lake
The Villages, Florida, United States
Medical Research Partners
Ammon, Idaho, United States
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, United States
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, United States
Knownwell
Needham, Massachusetts, United States
Lucida Clinical Trials
New Bedford, Massachusetts, United States
Headlands Research - Detroit
Southfield, Michigan, United States
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, United States
Clinvest Headlands Llc
Springfield, Missouri, United States
Las Vegas Medical Research
Las Vegas, Nevada, United States
Velocity Clinical Research, Syracuse
East Syracuse, New York, United States
Rochester Clinical Research, LLC
Rochester, New York, United States
Monroe Biomedical Research
Monroe, North Carolina, United States
Lucas Research, Inc
Morehead City, North Carolina, United States
Lucas Research, Inc.
New Bern, North Carolina, United States
Quality Medical Research
Nashville, Tennessee, United States
IMA Clinical Research Austin
Austin, Texas, United States
Velocity Clinical Research, Dallas
Dallas, Texas, United States
FutureSearch Trials of Dallas
Dallas, Texas, United States
PlanIt Research, PLLC
Houston, Texas, United States
Tekton Research - Fredericksburg Road
San Antonio, Texas, United States
Endeavor Clinical Trials
San Antonio, Texas, United States
Texas Valley Clinical Research
Weslaco, Texas, United States
Spectrum Medical, Inc.
Danville, Virginia, United States
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington, United States
Centro Médico Viamonte
Buenos Aires, Buenos Aires F.D., Argentina
Consultorio de Investigación Clínica EMO SRL
Buenos Aires, Buenos Aires F.D., Argentina
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Buenos Aires F.D., Argentina
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina